USO - Texas Oncology - San Antonio

San Antonio, Texas 78240

1 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Studies at this site

• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
• A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) — Running, not enrolling